MedTrace Logo

Study of a Novel Laser for Skin Rejuvenation

NCT02910492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-09-15

Study results available
· View outcomes & findings →

Summary

Single-center study to evaluate the safety and efficacy of an investigational version of the enlighten™ 670nm laser for photo-rejuvenation.

Conditions

  • Rejuvenation

Interventions

DEVICE

enLighten Laser

Dual-pulse duration laser for the treatment of skin rejuvenation

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, MD · Cutera Research Center

  • Omar Ibrahimi, MD · Connecticut Skin Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910492 on ClinicalTrials.gov